Vendola Keith A. 4
4 · IO Biotech, Inc. · Filed Nov 8, 2021
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Vendola Keith A.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-04+69,469→ 69,469 totalExercise: $14.00Exp: 2031-11-04→ Common Stock (69,469 underlying)
Footnotes (1)
- [F1]These options vest 25% on the one-year anniversary of the vesting commencement date of November 4, 2021, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.